TY  - JOUR
IS  - 322
JF  - Journal of BMC Neurology
EP  - 4
Y1  - 2022/08/26/
SP  - 1
KW  - moderna; vaccine; acute dizziness; mental alteration; encephalopathy
PB  - BioMed Central Ltd.
ID  - katalog9279
TI  - ACUTE DIZZINESS AND MENTAL ALTERATION ASSOCIATED WITH MODERNA COVID-19 VACCINE: A CASE REPORT
VL  - 22
AV  - public
N2  - Background
Due to a rising number of COVID-19 cases, the Indonesian government implemented public health programs to lower the rate. Since January 2021, one of the government?s primary policies has been the COVID-19 immunization program. Recently, the Moderna messenger ribonucleic acid (mRNA) vaccine is one of the COVID-19 vaccines used in Indonesia. Based on some research, Moderna has possible side effects throughout the body, including neurological symptoms.

Case presentation
We describe a 39-year-old female with uncontrolled hypertension who showed behavioral change, communication difficulty, social withdrawal, and a confused state within 7?days from getting her first dose of the Moderna vaccine. The patient had a history of febrile convulsion in childhood. An increase of neutrophil-to-lymphocyte ratio (16.9) and C-reactive protein level (31.75?mg/L) indicates ongoing inflammation. Head CT scan shows no abnormalities. She received ceftriaxone, citicoline, and methylprednisolone. The patient was discharged on the seventh day and completely recovered 1 week later. This study is the first case report of encephalopathy following the administration of the Moderna COVID-19 vaccine reported in Indonesia up to our knowledge.

Conclusion
Encephalopathy related to the Moderna COVID-19 vaccine should be acknowledged as an adverse effect of the Moderna COVID-19 vaccine.
SN  - 1471-2377
UR  - https://doi.org/10.1186/s12883-022-02834-8
A1  - Rizaldy Taslim Pinzon
ER  -